“Biotech’s diet in a bottle could extend your life.” How’s that for an eye-catching headline? It appears over a new BusinessWeek story, http://www.businessweek.com/magazine/content/06_12/b3976007.htm?campaign_id=rss_magzn, that talks about biotech firms working on calorie restricting drugs. It doesn’t mention Nastech Pharmaceutical’s PYY nasal spray by name, but that would certainly come under that category — assuming the drug works.
BusinessWeek’s story suggests that companies are working on these drugs as treatments for obesity and diabetes, but they may appeal to a wider audience as anti-aging tools, which would mean big sales figures.
Key quote: “They’re not youth pills, but they offer ways of intervening in the specific mechanisms of aging,” said Ronald M. Klatz, president of the American Academy of Anti-Aging Medicine.
For BusinessWeek’s related cover story on the promise of youth through biotech and related means, http://www.businessweek.com/magazine/content/06_12/b3976001.htm.
Talk to us
- You can tell us about news and ask us about our journalism by emailing newstips@heraldnet.com or by calling 425-339-3428.
- If you have an opinion you wish to share for publication, send a letter to the editor to letters@heraldnet.com or by regular mail to The Daily Herald, Letters, P.O. Box 930, Everett, WA 98206.
- More contact information is here.
